Eurekan Biotech wins a $150,000 research grant from the African Development Bank (AfDB) through the Directorate for Technical Cooperation in Africa (DTCA) to mine for siRNA "vaccines" from Bat tissues - as possible Ebola & Zika therapeutics.

The preliminary studies and sampling are to cover some African regions affected during the last Ebola pandemic which may include - Nigeria, Sierra-Leone and Liberia. Such studies are being supported to further help Africa prepare for possible future resurgence of these infectious diseases.

The study will be completed by a cohort of African scientists from Eurekan Biotech, Nigeria; ACEGID (African Centre of Excellence for the Genomics of Infectious Diseases) Ede, Nigeria; Bowen University, Iwo, Nigeria; University of Medical Sciences, Ondo, Nigeria; and Florida Atlantic University, USA.

Olumide Adenmosun, Eurekan Biotech's President/CEO bags an MBA at FAU - gets a commendation mention at the Summer 2017 graduation ceremony:

Among FAU’s summer grads: Student who saw Ebola outbreak, college mascot

Olumide Adenmosun of Eurekan Biotech partners with Bioinnovation Solutions, Lausanne Switzerland as a Product Development Consultant to develop Rapid Response Ebola Test (RRET) - a rapid genetic diagnostic test kit that detects Ebola virus from body fluids in 30mins. Validation tests were conducted at African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemers University, Mowe Ogun State Nigeria.

Nigerian scientists develop Ebola screening solutions - The Punch Newspapers 25th October, 2014

Nigerians unearth 30-minute test to detect Ebola - The Cable 22nd October, 2014

BioInnovation Solutions, Enzymatics Validate Isothermal Ebola MDx on West African Outbreak Samples - 8th December, 2014